@article{56d6fe8c580b41a8ac4f544e8296c75e,
title = "Meta-analysis of the efficacy and adverse effects of acalabrutinib in the management of relapsed/refractory chronic lymphocytic leukemia",
keywords = "Acalabrutinib, BTKi, Bruton tyrosine kinase inhibitor, relapsed/refractory chronic lymphocytic leukemia",
author = "Daniel Park and Chan-Golston, {Alec M.} and Yueqi Yan and Farris Al-Manaseer and Mojtaba Akhtari",
note = "Publisher Copyright: {\textcopyright} 2024 Edizioni Scientifiche per l'Informazione su Farmaci e Terapia (Italian Society of Chemotherapy).",
year = "2024",
doi = "10.1080/1120009X.2024.2357980",
language = "English",
journal = "Journal of Chemotherapy",
issn = "1120-009X",
}